RULES WERE NOT MEANT FOR THIS BMW. There's a reason the 2 Series is so loved. Blisteringly fast, the 335-horsepower rear-wheel drive M240i Coupe sprints from 0 to 60 mph in just 4.4 seconds, or 4.2 seconds with xDrive, and handles with a steering agility and control that are incredibly precise.
FDA Approves Tecentriq Immunotherapy for Specific Type of Advanced Lung Cancer. The U.S. Food and Drug Administration (FDA) approved Genentechâs Tecentriq (atezolizumab) as a treatment for people with metastatic non-small cell lung cancer (NSCLC).
On the Move. 1  Friday, April 14, 2017. 2  FDA rejects Lilly's marketing application for RA candidate baricitinib. Eli Lilly (NYSE:LLY) has received a Complete Response Letter (CRL) from the FDA regarding its New Drug Application (NDA) seeking approval of JAK inhibitor baricitinib for the treatment of moderate-to-severe rheumatoid arthritis (RA).